Replimune Group

Replimune Group Dividend per Share

Dividend per Share of Replimune Group (REPL) as of Oct 29, 2026.

Dividend per Share

0.00USD

Last updated:

Dividend per Share of Replimune Group is 2026 0.00 USD. Dividend per Share of Replimune Group was 2025 0.00 USD. It decreases by % lower compared to the previous year.

The Replimune Group Dividend per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend per Share
Date
Dividend per Share
Jan 1, 2024
0.00 USD
Jan 1, 2025
0.00 USD
Jan 1, 2026
0.00 USD
Jan 1, 2027 (e)
0.00 USD
Jan 1, 2028 (e)
0.00 USD
Jan 1, 2029 (e)
0.00 USD
Jan 1, 2030 (e)
0.00 USD
Jan 1, 2031 (e)
0.00 USD
The Replimune Group Dividend per Share history
YEARDividend per ShareYoY
est0.00USD—
est0.00USD—
est0.00USD—
est0.00USD—
est0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Replimune Group Stock analysis

What does Replimune Group do? Replimune Group Inc is an American biotechnology company based in Woburn, Massachusetts. The company focuses on the development of therapeutics for cancer treatments through the application of oncolytic viruses. Replimune Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Replimune Group stock

On Eulerpool you can find the complete historical development of Dividend per Share Replimune Group since 2006 – with annual values, charts, and detailed analysis.

Dividend per share is the total dividend payment divided by shares outstanding. It shows how much cash each share receives in dividends.

Dividend per Share's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend per Share's Replimune Group historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dividend — Replimune Group

All Key Metrics — Replimune Group